论文部分内容阅读
国家药品监督管理局已采取措施全面加快监督实施GMP,规定了GMP认证的最后时限,对于在规定时限内达不到GMP规范的企业不准生产药品。这对提高我国制药企业的管理水平和保证药品质量,应对入世后国外同行的挑战具有战略意义。为了更好地适应国家药品监督管理局的要求,使药品生产企
State Drug Administration has taken measures to speed up the supervision of the implementation of GMP, GMP certification provides the deadline, for those who fail to meet the GMP standard within the prescribed period of time are not allowed to produce drugs. It is of strategic importance to improve the management level of pharmaceutical enterprises in our country and ensure the quality of medicines to meet the challenge of foreign counterparts after joining WTO. In order to better meet the requirements of the State Drug Administration to enable drug manufacturers